Prolonged Cardiac Monitoring in Individuals with High Risk for Atrial Fibrillation and Stroke

Overview

About this study

The purpose of this study is to screen high-risk subjects with annual prolonged cardiac monitoring to determine the rate of subclinical atrial fibrillation detection.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion riteria:

≥18 years old.
Diagnoses of obesity and obstructive sleep apnea.
CHA2DS2-VASc score ≥2.
Baseline modified Rankin scale score 0-2.

Exclusion Criteria:

Prior history of atrial fibrillation or flutter.
Artificial heart valve or valve repair.
Mitral stenosis.
History of stroke or TIA.
Other indication for anticoagulation (ie: DVT, PE).
Known malignancy.
Pregnancy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Josephine Huang, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Melissa Rompola CCRP (904) 953-4516 Rompola.Melissa@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Josephine Huang, M.D.

Closed-enrolling by invitation

Contact information:

Melissa Rompola CCRP

(904) 953-4516

Rompola.Melissa@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials